IN2012DN02632A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02632A IN2012DN02632A IN2632DEN2012A IN2012DN02632A IN 2012DN02632 A IN2012DN02632 A IN 2012DN02632A IN 2632DEN2012 A IN2632DEN2012 A IN 2632DEN2012A IN 2012DN02632 A IN2012DN02632 A IN 2012DN02632A
- Authority
- IN
- India
- Prior art keywords
- hydroxyl
- hydrogen
- optionally substituted
- hydrocarbon group
- group optionally
- Prior art date
Links
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 102100024025 Heparanase Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- -1 cyclic carboxamide Chemical class 0.000 abstract 1
- 108010037536 heparanase Proteins 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009228406 | 2009-09-30 | ||
| PCT/JP2010/066998 WO2011040496A1 (ja) | 2009-09-30 | 2010-09-29 | ヘパラナーゼ活性阻害剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02632A true IN2012DN02632A (OSRAM) | 2015-09-04 |
Family
ID=43826308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2632DEN2012 IN2012DN02632A (OSRAM) | 2009-09-30 | 2010-09-29 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8609075B2 (OSRAM) |
| EP (1) | EP2484359B1 (OSRAM) |
| JP (2) | JP5593323B2 (OSRAM) |
| KR (1) | KR101431348B1 (OSRAM) |
| CN (1) | CN102655863B (OSRAM) |
| BR (1) | BR112012007090A2 (OSRAM) |
| ES (1) | ES2687780T3 (OSRAM) |
| IN (1) | IN2012DN02632A (OSRAM) |
| RU (1) | RU2503454C1 (OSRAM) |
| TW (1) | TWI461221B (OSRAM) |
| WO (1) | WO2011040496A1 (OSRAM) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5685369B2 (ja) * | 2009-09-15 | 2015-03-18 | 株式会社 資生堂 | ヘパラナーゼ阻害剤による美白方法及び美白効果を有する物質の評価方法 |
| JP2013032332A (ja) * | 2011-07-01 | 2013-02-14 | Lintec Corp | 免疫賦活剤 |
| JP5258993B1 (ja) * | 2012-03-29 | 2013-08-07 | 株式会社 資生堂 | ヘパラン硫酸産生促進剤 |
| JP6321506B2 (ja) * | 2014-09-22 | 2018-05-09 | 株式会社 資生堂 | ヘパラナーゼ阻害剤による美白方法及び美白効果を有する物質の評価方法 |
| WO2018074606A1 (ja) * | 2016-10-21 | 2018-04-26 | 株式会社資生堂 | ラミニン５１１産生促進剤、表皮基底膜安定化剤及び／又は表皮幹細胞減少抑制又は増加促進剤のスクリーニング方法 |
| JP2020503377A (ja) | 2016-12-13 | 2020-01-30 | ベータ セラピューティクス プロプライアタリー リミティド | ヘパラナーゼ阻害剤及びそれの使用 |
| US11787783B2 (en) | 2016-12-13 | 2023-10-17 | Beta Therapeutics Pty Ltd | Heparanase inhibitors and use thereof |
| EP3381897A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer |
| EP3381898A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Symmetrical tris-aryl-amide derivatives and their use as anti-heparanase |
| EP3381906A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Compounds for use as heparanase inhibitors |
| EP3381907A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Symmetrical 2-aminophenyl-benzazolyl-5-acetate compounds and their use as anti-heparanase |
| EP3381908A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | 2-(4-(4-(bromo-methoxybenzamido)benzylamino)phenyl)benzazole derivatives and their use as anti-heparanase |
| EP3388439A1 (en) | 2017-04-11 | 2018-10-17 | Leadiant Biosciences SA | Biotin-conjugated n-acetyl glycol split heparin |
| AU2018282841B2 (en) | 2017-06-13 | 2024-03-28 | National Cancer Center | Carcinogenesis inhibitor |
| US20220202964A1 (en) * | 2019-04-24 | 2022-06-30 | University Of Florida Research Foundation, Incorporated | Heparanase compounds and methods of use |
| EP4230192A4 (en) | 2020-12-15 | 2025-06-11 | Shiseido Company, Ltd. | AGENT PROMOTING THE PROLIFERATION OF EPIDERMAL STEM CELLS |
| WO2022131108A1 (ja) * | 2020-12-15 | 2022-06-23 | 株式会社 資生堂 | 真皮再生促進剤 |
| JPWO2023100684A1 (OSRAM) | 2021-12-02 | 2023-06-08 | ||
| CN118201590A (zh) * | 2021-12-03 | 2024-06-14 | 株式会社资生堂 | 化妆品 |
| JPWO2023106123A1 (OSRAM) * | 2021-12-09 | 2023-06-15 | ||
| JPWO2023106121A1 (OSRAM) * | 2021-12-09 | 2023-06-15 | ||
| JPWO2023120180A1 (OSRAM) * | 2021-12-20 | 2023-06-29 | ||
| CN118510490A (zh) | 2022-02-03 | 2024-08-16 | 株式会社资生堂 | 皮肤外用组合物 |
| US20250082559A1 (en) | 2022-02-03 | 2025-03-13 | Shiseido Company, Ltd. | External-use skin preparation composition |
| WO2023149227A1 (ja) | 2022-02-03 | 2023-08-10 | 株式会社 資生堂 | 皮膚外用組成物 |
| WO2025142503A1 (ja) * | 2023-12-26 | 2025-07-03 | 株式会社資生堂 | むくみ改善剤及び化粧料 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1256235A (en) * | 1917-03-31 | 1918-02-12 | William F Jacobs | Work-supporting horse. |
| US4049650A (en) | 1976-10-18 | 1977-09-20 | Morton-Norwich Products, Inc. | 1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones |
| US4593038A (en) * | 1985-04-03 | 1986-06-03 | Burzynski Stanislaw R | Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation |
| US4731453A (en) | 1985-04-03 | 1988-03-15 | Mitsui Toatsu Chemicals, Inc. | Process for producing 1, 3-dialkyl-2-imidazolidinone |
| US4960771A (en) | 1988-07-12 | 1990-10-02 | Rajadhyaksha Vithal J | Oxazolidinone penetration enhancing compounds |
| US5011621A (en) | 1990-06-04 | 1991-04-30 | Arco Chemical Technology, Inc. | Paint stripper compositions containing N-methyl-2-pyrrolidone and renewable resources |
| US5583256A (en) | 1994-07-07 | 1996-12-10 | Mitsui Toatsu Chemicals, Inc. | Process for producing 1,3-dialkyl-2-imidazolidinone |
| US5536740A (en) * | 1995-06-01 | 1996-07-16 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester |
| US5837224A (en) | 1996-01-19 | 1998-11-17 | The Regents Of The University Of Michigan | Method of inhibiting photoaging of skin |
| JPH11335235A (ja) | 1998-05-22 | 1999-12-07 | Shiseido Co Ltd | 抗老化剤 |
| GB9913415D0 (en) | 1999-06-10 | 1999-08-11 | Central Manchester Healthcare | Heparanase assay |
| JP2001163794A (ja) | 1999-12-03 | 2001-06-19 | Shiseido Co Ltd | ヒアルロン酸産生促進剤および皮膚外用剤 |
| TWI233361B (en) | 2001-04-13 | 2005-06-01 | Gen Hospital Corp | Methods of preventing UVB-induced skin damage |
| US20030129259A1 (en) * | 2001-12-28 | 2003-07-10 | Avon Products, Inc. | Topical lightening compostitions and methods of use |
| ATE300280T1 (de) * | 2002-02-15 | 2005-08-15 | Goldschmidt Gmbh | Verwendung von kreatinin und/oder kreatinin- derivaten zur aufhellung der haut und milderung von pigmentstörungen |
| WO2003084302A2 (en) | 2002-06-25 | 2003-10-16 | Shiseido Co Ltd | Anti-aging agent |
| CA2537991A1 (en) * | 2003-09-23 | 2005-03-31 | Novartis Ag | Combination of a vegf receptor inhibitor with a chemotherapeutic agent |
| NZ547689A (en) * | 2003-11-19 | 2009-05-31 | Signal Pharm Llc | Indazole compounds and methods of use thereof as protein kinase inhibitors |
| FR2873377B1 (fr) * | 2004-07-23 | 2006-10-13 | Sanofi Synthelabo | Derives d'azasucre, inhibiteurs d'heparanases, leur procede de preparation, les compositions en contenant et leur utilisation |
| US7238260B2 (en) | 2004-10-26 | 2007-07-03 | Lyondell Chemical Technology, L.P. | Purification of N-(2-hydroxyethyl)-2-pyrrolidone |
| JP2006303185A (ja) | 2005-04-20 | 2006-11-02 | Matsushita Electric Ind Co Ltd | 半導体装置及びその製造方法 |
| JP2007277149A (ja) | 2006-04-06 | 2007-10-25 | Kao Corp | インボルクリン発現促進剤 |
| US8097581B2 (en) | 2007-05-10 | 2012-01-17 | Grant Industries Inc. | Anti-wrinkle cosmetic composition |
| CN101311188B (zh) * | 2007-05-21 | 2010-12-29 | 中国人民解放军军事医学科学院生物工程研究所 | 人乙酰肝素酶的小分子多肽抑制剂 |
| JP2008303187A (ja) * | 2007-06-08 | 2008-12-18 | Shiseido Co Ltd | コーニファイドエンベロープ形成・成熟化促進剤 |
| JP5179096B2 (ja) * | 2007-06-08 | 2013-04-10 | 株式会社 資生堂 | コーニファイドエンベロープ形成・成熟化促進剤 |
| JP5105962B2 (ja) | 2007-06-08 | 2012-12-26 | 株式会社 資生堂 | コーニファイドエンベロープ形成・成熟化促進剤 |
| US20110020477A1 (en) | 2008-03-31 | 2011-01-27 | Shiseido Company, Ltd. | Oral preparation, injection preparation, external skin preparation and cosmetic method for preventing or improving wrinkles |
| WO2009122540A1 (ja) * | 2008-03-31 | 2009-10-08 | 株式会社資生堂 | しわを防止または改善するための経口、注射、皮膚外用剤および美容方法 |
| FR2931064B1 (fr) | 2008-05-14 | 2010-08-13 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane |
-
2010
- 2010-09-29 IN IN2632DEN2012 patent/IN2012DN02632A/en unknown
- 2010-09-29 CN CN2010800438641A patent/CN102655863B/zh active Active
- 2010-09-29 EP EP10820611.1A patent/EP2484359B1/en active Active
- 2010-09-29 ES ES10820611.1T patent/ES2687780T3/es active Active
- 2010-09-29 KR KR1020127004685A patent/KR101431348B1/ko active Active
- 2010-09-29 BR BR112012007090-8A patent/BR112012007090A2/pt not_active Application Discontinuation
- 2010-09-29 WO PCT/JP2010/066998 patent/WO2011040496A1/ja not_active Ceased
- 2010-09-29 JP JP2011534288A patent/JP5593323B2/ja active Active
- 2010-09-29 US US13/261,244 patent/US8609075B2/en active Active
- 2010-09-29 RU RU2012117797/15A patent/RU2503454C1/ru not_active IP Right Cessation
- 2010-09-30 TW TW099133410A patent/TWI461221B/zh active
-
2013
- 2013-11-18 US US14/082,440 patent/US8901160B2/en active Active
-
2014
- 2014-02-10 JP JP2014023264A patent/JP2014111640A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011040496A1 (ja) | 2011-04-07 |
| KR101431348B1 (ko) | 2014-08-19 |
| US8901160B2 (en) | 2014-12-02 |
| RU2012117797A (ru) | 2013-11-10 |
| ES2687780T3 (es) | 2018-10-29 |
| HK1171390A1 (en) | 2013-03-28 |
| CN102655863A (zh) | 2012-09-05 |
| TW201117832A (en) | 2011-06-01 |
| JP5593323B2 (ja) | 2014-09-24 |
| US8609075B2 (en) | 2013-12-17 |
| BR112012007090A2 (pt) | 2018-06-05 |
| JPWO2011040496A1 (ja) | 2013-02-28 |
| US20140080878A1 (en) | 2014-03-20 |
| JP2014111640A (ja) | 2014-06-19 |
| US20120183481A1 (en) | 2012-07-19 |
| AU2010301641A1 (en) | 2012-03-22 |
| EP2484359A4 (en) | 2015-07-08 |
| EP2484359A1 (en) | 2012-08-08 |
| KR20120060205A (ko) | 2012-06-11 |
| EP2484359B1 (en) | 2018-07-25 |
| TWI461221B (zh) | 2014-11-21 |
| RU2503454C1 (ru) | 2014-01-10 |
| CN102655863B (zh) | 2013-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02632A (OSRAM) | ||
| BR112012013049A2 (pt) | potencializador do efeito antitumor. | |
| MX338707B (es) | Compuestos heterociclicos activadores de proteina cinasa activada por 5'-amp (ampk) y metodos para emplearlos. | |
| MY160359A (en) | Low-molecular polysulfated hyaluronic acid derivative and medicine containing same | |
| TW201000473A (en) | Benzene or thiophene derivative and use thereof as VAP-1 inhibitor | |
| UA108510C2 (xx) | Циклопропанова сполука | |
| MY156669A (en) | Pesticidal composition and its use | |
| GEP20156309B (en) | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 | |
| EA201890254A3 (ru) | Ингибиторы глюкозилцерамидсинтазы | |
| ATE542813T1 (de) | 6-substituierte 2- heterocyclylaminopyrazinverbindungen als chk-1- inhibitoren | |
| IN2012DN01350A (OSRAM) | ||
| NO20083717L (no) | Pyrrolotriazin-anilin prodrugforbindelser anvendbare som kinaseinhibitorer | |
| MY155658A (en) | A-isopropylphenyl glucitol compounds as sglti inhibitors | |
| BR112016013299A2 (pt) | Composto | |
| MX363956B (es) | Agente de control de plagas. | |
| NO20090856L (no) | STAT3/5 activeringsinhibitor | |
| IN2012DN00694A (OSRAM) | ||
| MX2011009423A (es) | Compuesto de piperazina capaz de inhibir prostaglandina d sintasa. | |
| NO20091746L (no) | Nytt difenylazetidinon substituert med piperazin-1-sulfonsyre med forbedrede farmakologiske egenskaper | |
| GB2515909A (en) | Polymer | |
| PH12013502111A1 (en) | Method for promoting plant growth | |
| MY178106A (en) | 1,4-butanediol-containing composition | |
| GEP20156295B (en) | 1,4-oxazepane derivatives | |
| WO2012024397A3 (en) | 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | |
| MY179437A (en) | Preventing or ameliorating agent for pigmentation |